Related Experiment Video
Updated: Jun 11, 2026
08:01
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Multimodality approach to malignant pleural mesothelioma. A case report
Carlo Pala1, Panagiotis Paliogiannis, Fernando Serventi
1Istituto di Patologia Chirurgica, Università degli Studi di Sassari, Italia.
Annali Italiani Di Chirurgia
|July 3, 2010
Summary
This case study highlights diffuse malignant pleural mesothelioma (DMPM) treatment. Multimodality therapy, including surgery and chemotherapy, improved survival and quality of life for this patient.
Area of Science:
- Oncology
- Thoracic Surgery
- Pulmonology
Background:
- Diffuse malignant pleural mesothelioma (DMPM) is a rare and aggressive cancer.
- Asbestos exposure is a primary risk factor for DMPM.
- Diagnosis often involves imaging, thoracoscopy, and histology.
Observation:
- A 68-year-old male presented with right-sided pleural effusion, dyspnea, and chest pain.
- Initial investigations (thoracentesis, CT scan) were inconclusive for malignancy.
- Videothoracoscopy revealed nodular lesions on the parietal pleura, diagnosed as epithelial DMPM with sarcomatoid areas.
Findings:
- The patient underwent Extrapleural Pleuropneumonectomy followed by Cisplatin and Pemetrexed chemotherapy.
- A disease-free period of one year was achieved.
- The patient survived for 31 months, succumbing to septic complications.
Implications:
- Single treatment modalities show limited efficacy for DMPM.
- Multimodality therapy offers improved survival and quality of life for DMPM patients.
- This case underscores the importance of a comprehensive treatment approach for DMPM.
